TransMedics Group Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Revenue	441.54	241.62	93.46	30.26	25.64	Upgrade
Revenue Growth (YoY)	82.74%	158.53%	208.83%	18.03%	8.62%	Upgrade
Cost of Revenue	179.46	87.53	28.19	9.1	9	Upgrade
Gross Profit	262.08	154.09	65.27	21.16	16.64	Upgrade
Selling, General & Admin	168.62	117.55	69.9	38.28	24.19	Upgrade
Research & Development	55.97	36.06	26.81	22.3	18.83	Upgrade
Operating Expenses	224.59	153.61	96.71	60.59	43.02	Upgrade
Operating Income	37.5	0.49	-31.44	-39.43	-26.38	Upgrade
Interest Expense	-14.41	-10.79	-3.73	-3.87	-3.99	Upgrade
Interest & Investment Income	13.4	12.5	-	-	-	Upgrade
Currency Exchange Gain (Loss)	0.7	0.3	-	-1	1	Upgrade
Other Non Operating Income (Expenses)	-1.41	0.05	-0.43	0.12	0.65	Upgrade
EBT Excluding Unusual Items	35.78	2.54	-35.59	-44.18	-28.72	Upgrade
Merger & Restructuring Charges	-	-2	-	-	-	Upgrade
Other Unusual Items	-	-	-0.58	-	-	Upgrade
Pretax Income	35.78	-26.67	-36.17	-44.18	-28.72	Upgrade
Income Tax Expense	0.32	-1.64	0.07	0.04	0.03	Upgrade
Net Income	35.46	-25.03	-36.23	-44.22	-28.75	Upgrade
Net Income to Common	35.46	-25.03	-36.23	-44.22	-28.75	Upgrade
Shares Outstanding (Basic)	33	33	30	28	25	Upgrade
Shares Outstanding (Diluted)	35	33	30	28	25	Upgrade
Shares Change (YoY)	8.30%	10.02%	7.02%	11.80%	73.91%	Upgrade
EPS (Basic)	1.07	-0.77	-1.23	-1.60	-1.16	Upgrade
EPS (Diluted)	1.01	-0.77	-1.23	-1.60	-1.16	Upgrade
Free Cash Flow	-80.94	-164.88	-57.72	-32.38	-30.72	Upgrade
Free Cash Flow Per Share	-2.30	-5.07	-1.95	-1.17	-1.24	Upgrade
Gross Margin	59.36%	63.77%	69.84%	69.92%	64.88%	Upgrade
Operating Margin	8.49%	0.20%	-33.64%	-130.29%	-102.91%	Upgrade
Profit Margin	8.03%	-10.36%	-38.77%	-146.11%	-112.13%	Upgrade
Free Cash Flow Margin	-18.33%	-68.24%	-61.76%	-107.01%	-119.82%	Upgrade
EBITDA	57.25	8.66	-27.96	-37.61	-24.81	Upgrade
EBITDA Margin	12.97%	3.58%	-29.92%	-124.28%	-96.75%	Upgrade
D&A For EBITDA	19.76	8.18	3.48	1.82	1.58	Upgrade
EBIT	37.5	0.49	-31.44	-39.43	-26.38	Upgrade
EBIT Margin	8.49%	0.20%	-33.64%	-130.29%	-102.91%	Upgrade
Effective Tax Rate	0.88%	-	-	-	-	Upgrade
Revenue as Reported	441.54	241.62	93.46	30.26	25.64	Upgrade

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q